Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_assertion type Assertion NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_head.
- NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_assertion description "[Patients with IL-1 RA level in ascites lower than the cut off value of 695.6 pg/ml showed a significant better progression-free median survival (24.6 vs. 12.8 months, p=0.008) and postoperative median overall survival (34.6 vs. 17 months, p=0.01) in comparison to patients with an IL-1 RA level in ascites higher than the cut off level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_provenance.
- NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_assertion evidence source_evidence_literature NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_provenance.
- NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_assertion SIO_000772 18329282 NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_provenance.
- NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_assertion wasDerivedFrom befree-20140225 NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_provenance.
- NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_assertion wasGeneratedBy ECO_0000203 NP422723.RAVnZy791UruE8t4iEkdpqleCKaw-RXB9h8J3TYP-LoxU130_provenance.